CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-09 | Eansor Norman David President-Protein Sciences | Shares withheld for taxes | −856 | $265.76 | $227K | 1,318 |
| 2020-08-09 | Eansor Norman David President-Protein Sciences | Option exercise · Restricted Stock Units | −2,174 | 0 | ||
| 2020-08-09 | Hippel James Chief Financial Officer | Option exercise | +4,438 | 11,321 | ||
| 2020-08-09 | Hippel James Chief Financial Officer | Shares withheld for taxes | −2,184 | $265.76 | $580K | 9,137 |
| 2020-08-09 | Hippel James Chief Financial Officer | Option exercise · Restricted Stock Units | −4,438 | 0 | ||
| 2020-08-09 | Kummeth Charles R. Chief Executive Officer | Option exercise | +21,291 | 173,774 | ||
| 2020-08-09 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −12,287 | $265.76 | $3.3M | 161,487 |
| 2020-08-09 | Kummeth Charles R. Chief Executive Officer | Option exercise · Restricted Stock Units | −21,291 | 0 | ||
| 2020-08-05 | Kummeth Charles R. Chief Executive Officer | Grant or award | +8,586 | 152,483 | ||
| 2020-08-05 | Kummeth Charles R. Chief Executive Officer | Grant or award · Restricted Stock Units | +12,879 | 12,879 | ||
| 2020-08-05 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +57,442 | 57,442 | ||
| 2020-08-05 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +38,295 | 38,295 | ||
| 2020-08-05 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +16,650 | 16,650 | ||
| 2020-08-05 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +16,650 | 16,650 | ||
| 2020-08-05 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Restricted Stock Units | +2,015 | 2,015 | ||
| 2020-08-05 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Stock Options (Right to Buy) | +8,991 | 8,991 | ||
| 2020-08-05 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Stock Options (Right to Buy) | +11,988 | 11,988 | ||
| 2020-08-05 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Stock Options (Right to Buy) | +8,325 | 8,325 | ||
| 2020-08-05 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Stock Options (Right to Buy) | +8,325 | 8,325 | ||
| 2020-08-05 | Hippel James Chief Financial Officer | Grant or award · Restricted Stock Units | +3,219 | 3,219 |
Page 41 of 53 · 1,043 trades